Aditya Birla Sun Life Pharma And Healthcare Fund-Regular-Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-07-2019
AUM:
₹ 1,077.52 Cr
Expense Ratio
2.29%
Benchmark
BSE Healthcare TRI
ISIN
INF209KB1N91
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Dhaval Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Aditya Birla Sun Life Pharma And Healthcare Fund-Regular-Growth | 10.68 | 18.81 | 12.51 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
34.51
Last change
0.68 (1.9704%)
Fund Size (AUM)
₹ 1,077.52 Cr
Performance
18.41% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Fund Manager
Mr. Dhaval Shah
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 9.28 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.61 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 6.44 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.38 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.52 |
| Sai Life Sciences Limited | 4.49 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 4.35 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.62 |
| DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/- | 3.51 |
| ABBOTT INDIA LIMITED EQ | 3.26 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 96.52 |
| Financial Services | 0.73 |
| Chemicals | 0.69 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| ABSL Pharma And Healthcare Reg Gr | 12.51 |